MicroRNA Polymorphisms As Markers of Risk, Prognosis and Treatment Response in Hematological Malignancies
Overview
Authors
Affiliations
MicroRNA dysregulation is a common event in hematological malignancies. Apart from genomic and epigenetic alterations, miRNA networks may be disturbed by polymorphisms in the miRNA regulatory pathway (miRSNPs). In this review we provide an overview of three categories of miRSNPs: (1) SNPs in genes involved in miRNA biogenesis and processing; (2) SNPs in miRNA genes; and (3) SNPs in miRNA binding sites in target genes and discuss their potential role as markers of disease risk, prognosis and treatment response in hematological cancers. Although so far only the tip of the iceberg has been touched, studies of polymorphisms in the miRNA regulatory pathways have already provided some clues for the mechanisms of miRNA dysregulation in cancer and open new perspectives in the management of hematological malignancies.
Siyadat P, Ayatollahi H, Barati M, Sheikhi M, Shahidi M Rep Biochem Mol Biol. 2021; 9(4):385-393.
PMID: 33969131 PMC: 8068442. DOI: 10.52547/rbmb.9.4.385.
miR-618 rs2682818 C>A polymorphism decreases Hirschsprung disease risk in Chinese children.
Zheng Y, Lu T, Xie X, He Q, Lu L, Zhong W Biosci Rep. 2020; 40(5).
PMID: 32364585 PMC: 7214396. DOI: 10.1042/BSR20193989.
The CCR4-NOT complex maintains liver homeostasis through mRNA deadenylation.
Takahashi A, Suzuki T, Soeda S, Takaoka S, Kobori S, Yamaguchi T Life Sci Alliance. 2020; 3(5).
PMID: 32238456 PMC: 7119370. DOI: 10.26508/lsa.201900494.
Bradshaw G, Haupt L, Aquino E, Lea R, Sutherland H, Griffiths L Genes (Basel). 2019; 10(3).
PMID: 30818878 PMC: 6471575. DOI: 10.3390/genes10030185.
The Role of Exportin-5 in MicroRNA Biogenesis and Cancer.
Wu K, He J, Pu W, Peng Y Genomics Proteomics Bioinformatics. 2018; 16(2):120-126.
PMID: 29723684 PMC: 6112314. DOI: 10.1016/j.gpb.2017.09.004.